A 35-year-old woman from Kolkata presents with a 7-day history of high fever, headache, and abdominal pain. Blood culture grows Salmonella typhi. She is started on ceftriaxone 2 g IV 12-hourly. On day 5 of therapy, she develops severe diarrhea with bloody stools and signs of peritonitis (rigid abdomen, rebound tenderness). Abdominal imaging shows free fluid. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient has enteric fever complicated by **intestinal perforation with peritonitis**, a life-threatening complication occurring in 1–5% of cases, typically in the second to third week of illness. The presence of bloody diarrhea, rigid abdomen, rebound tenderness, and free fluid on imaging indicates acute peritoneal involvement. ## Pathophysiology of Typhoid Perforation **Key Point:** Salmonella typhi causes hyperplasia and necrosis of Peyer's patches in the terminal ileum, leading to perforation. This is a surgical emergency with high mortality if not managed promptly. ## Management Algorithm for Typhoid Perforation ```mermaid flowchart TD A[Enteric fever + peritonitis signs]:::outcome --> B{Imaging confirms free fluid/perforation?}:::decision B -->|Yes| C[Surgical consultation URGENT]:::urgent C --> D[Continue/optimize ceftriaxone]:::action D --> E[Add metronidazole for anaerobic coverage]:::action E --> F{Surgical intervention indicated?}:::decision F -->|Yes| G[Exploratory laparotomy + primary repair]:::action F -->|No| H[Close monitoring + serial imaging]:::action G --> I[Postoperative antibiotics continued]:::outcome ``` ## Antibiotic Management in Perforation | Aspect | Consideration | |--------|---------------| | **Continue ceftriaxone?** | Yes — effective against S. typhi and gram-negatives | | **Add metronidazole?** | Yes — covers anaerobes (Bacteroides, Peptostreptococcus) from intestinal flora | | **Switch to fluoroquinolone?** | No — inadequate for polymicrobial peritonitis; resistance high in India | | **Switch to chloramphenicol?** | No — inferior to cephalosporins; does not provide anaerobic coverage | | **Timing of surgery** | Urgent consultation; decision based on imaging and clinical stability | **High-Yield:** Typhoid perforation requires **dual antibiotic coverage** (aerobic + anaerobic) PLUS urgent surgical evaluation. Do NOT delay surgery for additional imaging or antibiotic trials. ## Clinical Features Mandating Surgical Consultation - Peritoneal signs (rigid abdomen, rebound, guarding) - Free fluid on imaging (ultrasound or CT) - Hemodynamic instability - Failure to improve on antibiotics within 48–72 hours - Imaging evidence of perforation (pneumoperitoneum, loculated abscess) **Clinical Pearl:** In endemic areas (India), typhoid perforation should be suspected in any enteric fever patient who develops acute abdominal signs during the second week of illness. ## Why Metronidazole Is Essential **Key Point:** Perforation introduces anaerobic bacteria (normal intestinal flora) into the peritoneal cavity. Ceftriaxone alone does NOT reliably cover anaerobes; metronidazole (500 mg IV 8-hourly) is mandatory. ## Surgical Management - **Primary repair** (preferred): Single-layer closure of perforation site; lower morbidity - **Resection + anastomosis**: If multiple perforations or extensive necrosis - **Timing**: Urgent (within 6–12 hours of diagnosis) - **Outcome**: Mortality ~5–10% with early surgery; >30% with delayed intervention **Warning:** Delaying surgery to "try antibiotics" significantly increases mortality. Surgical consultation must be concurrent with antibiotic initiation. ## Why Other Options Are Incorrect **Option 1 (Correct):** Combines appropriate dual antibiotic therapy (ceftriaxone + metronidazole), urgent surgical consultation, and imaging confirmation — the standard of care for typhoid perforation. **Option 2 (Diagnostic peritoneal lavage):** This invasive diagnostic procedure is rarely needed when imaging (ultrasound/CT) already confirms free fluid. It delays surgical consultation and is not indicated in the modern era. **Option 3 (Fluoroquinolone switch):** Fluoroquinolones are inadequate for polymicrobial peritonitis and have poor anaerobic coverage. High resistance rates in India make this inappropriate. Observation without surgery is dangerous. **Option 4 (Chloramphenicol switch):** Chloramphenicol is inferior to cephalosporins for S. typhi and does not provide anaerobic coverage. Switching away from ceftriaxone is a step backward and delays appropriate management.